Genetic changes in Chinese breast cancer patients
Part of Cancer, Skin clinical trials.
This study looks at the genetic changes in breast cancer patients, especially those with a family history or early onset. It may help doctors understand which genes are common in Chinese breast cancer patients and guide future treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer (confirmed by biopsy) and fall into at least one of these groups: triple-negative, age 50 or younger, male, you or a family member had certain cancers, or your cancer is HER-2 negative and has spread or is high-risk.
- You have had or are planning to get genetic testing for DNA repair genes (like BRCA).
- You are willing to share your medical records and genetic test results for research and long-term follow-up.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how genomic tests (which analyze your tumor's genes) are used in routine care for early-stage breast cancer that is hormone-sensitive. It may help doctors understand who really needs chemotherapy in addition to hormone therapy.
This trial studies breast cancer tumors to see how specific gene changes and DNA damage patterns relate to the cancer in people with HER2-low disease. It may help doctors better predict which patients could benefit from treatments that target these pathways.
This study looks at the genetic and protein markers of early breast cancer in Pakistani women. It aims to understand the disease better and possibly guide future treatments.
This study looks back at treatments given to people with triple-negative or HER2-positive early breast cancer between 2016 and 2021. It aims to understand how treatment approaches have changed over time.
This study looks at families in China who have breast cancer that runs in the family. It focuses on people who carry inherited gene changes that raise breast cancer risk. By joining, you may help doctors understand how these genes affect patients and their families.
This trial studies early, hormone receptor–positive, HER2-negative breast cancer and looks at a group with “high clinical risk” but “low genetic (tumor) risk.” It may help researchers understand which patients may benefit most from treatment decisions guided by genetic tumor testing.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.